Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Lele45g0525 | ATGTCCATGTCCACCTCTAGAACCCTAGATTCTTCTTCCTCCTCCTCCTCATCATTCAAAGGCTATGAAGCAAACCAGACCCAGATGGTTCTGTCTCTTCTTCAGAGAAACACATCTCCTTGTGATGGTGAGAAAAGAGGGAGAAGAAAGCAATCAGAACCGGGAAGGTTCCTTGGTGTCAGAAGAAGACCTTGGGGAAGATATGCTGCAGAAATAAGGGACCCCACAACAAAAGAAAGGCATTGGCTTGGAACTTTTGACACTGCTCAAGAAGCTGCTCTGGCTTATGACAGAGCTGCTCTCTCCATGAAAGGAAGCCAAGCAAGAACAAATTTCATATACTCTGACACTAACACTACTTTTCACTCTCTTCTTTCTCCTTCTTTAGATGTTCATCAACCACTTTTACCAACTTGTTATCAGAATAGTGCTAGTTCAGTAGTTTCTGATATGTCTCATCTTCATCAGATTGAGCCTAATAATAATAATAATCTGATGAACAATGGCATGCCTGAAACTGAGAACTTTTTCTTGTTTTCCAGTGATTATTCTTCTTCTAACTCAGGATACTTGGAATGTGTGGTTCCTGATAACTGTCTGAGAAGTTCAAGTGATCACCAAAAGGGTCAATCTCAACAACAACAACAAGGAATGATCAAAATGCCAACAGTGGGATGTGAAAGTTCAGATTTTTATTCATACCCAGATGAAATCTCTCAGGGATTTTCATGGGATTCTGATTGCAGTGAGCTTTCTGCTATAATCGACAGAAACCCAATAATGAGGGTTGAAGAAGATGATGGTGGGTGCTTCTTTGGGAGTTCTTCAAGCTATGGTGGGCTCATGATGACTGATCAATATGCTTCTGTTTCTGCTTCTGCTTCAGCTTCAGCTTCTTCTTCTTCTTCTTCTTCTTCATATGCCTTTGGAGATGTTGATATGGGATCCTCAATGTTCTGA | 960 | 0.4094 | MSMSTSRTLDSSSSSSSSFKGYEANQTQMVLSLLQRNTSPCDGEKRGRRKQSEPGRFLGVRRRPWGRYAAEIRDPTTKERHWLGTFDTAQEAALAYDRAALSMKGSQARTNFIYSDTNTTFHSLLSPSLDVHQPLLPTCYQNSASSVVSDMSHLHQIEPNNNNNLMNNGMPETENFFLFSSDYSSSNSGYLECVVPDNCLRSSSDHQKGQSQQQQQGMIKMPTVGCESSDFYSYPDEISQGFSWDSDCSELSAIIDRNPIMRVEEDDGGCFFGSSSSYGGLMMTDQYASVSASASASASSSSSSSSYAFGDVDMGSSMF | 319 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Lele45g0525 | 319 | CDD | AP2 | 56 | 112 | IPR001471 | GO:0003700|GO:0006355 | |
Lele45g0525 | 319 | ProSiteProfiles | AP2/ERF domain profile. | 56 | 113 | IPR001471 | GO:0003700|GO:0006355 | |
Lele45g0525 | 319 | MobiDBLite | consensus disorder prediction | 41 | 57 | - | - | |
Lele45g0525 | 319 | PANTHER | AP2 DOMAIN CLASS TRANSCRIPTION FACTOR | 36 | 251 | - | - | |
Lele45g0525 | 319 | Gene3D | AP2/ERF domain | 56 | 114 | IPR036955 | GO:0003700|GO:0006355 | |
Lele45g0525 | 319 | MobiDBLite | consensus disorder prediction | 37 | 57 | - | - | |
Lele45g0525 | 319 | Pfam | AP2 domain | 59 | 105 | IPR001471 | GO:0003700|GO:0006355 | |
Lele45g0525 | 319 | SUPERFAMILY | DNA-binding domain | 57 | 114 | IPR016177 | GO:0003677 | |
Lele45g0525 | 319 | PRINTS | Ethylene responsive element binding protein signature | 79 | 95 | IPR001471 | GO:0003700|GO:0006355 | |
Lele45g0525 | 319 | PRINTS | Ethylene responsive element binding protein signature | 57 | 68 | IPR001471 | GO:0003700|GO:0006355 | |
Lele45g0525 | 319 | SMART | rav1_2 | 56 | 119 | IPR001471 | GO:0003700|GO:0006355 | |
Lele45g0525 | 319 | MobiDBLite | consensus disorder prediction | 1 | 22 | - | - | |
Lele45g0525 | 319 | FunFam | Ethylene-responsive transcription factor 2 | 56 | 114 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Lele45g0525 | Lele-ChrLele45 | 4141595 | 4142554 | Dispersed/Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Lele45g0525 | 3 | 319 | AP2-EREBP Transcription Factor Family | AT5G18560 | 37.795 | 1.49e-58 | 190 |